Equibles does not estimate personal net worth.
Get an email with a short summary when Sutro Biopharma, Inc. publishes a filing, an earnings call transcript or a press release.
Get STRO alertsJane Chang is recorded as CEO at Sutro Biopharma, Inc. (STRO). Jane Chang has spoken on 1 investor event across 1 company, most recently for Sutro Biopharma, Inc. on June 4, 2026. Sutro Biopharma, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Sutro Biopharma, Inc. includes Jane Chung (CEO, COO and Board Member), Gregory Chow (CFO), Gregory K. Chow (CFO) and 5 others.
“Yeah, so our Tissue Factor ADC is designed, it's a beta-glued DART-8 Exatecan payload ADC. How we're designing our ADCs is fundamentally different. We are trying to optimize both for efficacy as well as safety.”
Biotechnology · Healthcare
CEO
